600 patients66,869 observations120 daysLIVE

Patient P-01786

Synthetic patientNBL-101 · Day 94 · 65–74 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
81%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S07
  2. Day 48 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 57 ME-01 recommendedMonitoring Escalation ME-01
  4. Day 58 Patient acceptedStarted ME-01 in the companion
  5. Day 61 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 48.

Primary contributors, last 14 days
  • Toxicity-11
  • GI instability-8
  • Treatment adherence-8
  • Inflammatory activity-7
  • Nutritional resilience+5

What helped?

  • Monitoring Escalation ME-01Day 57
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
87%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
58.9/100
improving · -7.4 vs previous 14 d
Toxicity
Blood
47.1/100
worsening · +5.9 vs previous 14 d
Sleep quality
Wearable
40.7/100
improving · +1.8 vs previous 14 d
Energy level
Daily log
2.5/10
improving · +0.2 vs previous 14 d
Stress level
Daily log
6.5/10
improving · -0.6 vs previous 14 d
Steps
Wearable
1,052
improving · +115 vs previous 14 d
Adherence
Companion
41.4 %
worsening · -14.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 26 from the failing basin, 63 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 90%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 76%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 76%
Would not help
  • Keep fat low
    GI +5.8 next day on high-intake days · n 26
  • Keep simple carbs low
    GI +5.8 next day on high-intake days · n 21
  • Keep fibre low
    GI +4 next day on high-intake days · n 12
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5.8detractor · 95%
  • Simple carbohydrates
    +5.8detractor · 95%
  • Insoluble fibre
    +4detractor · 61%
  • Spicy / capsaicin
    +2.6no signal · 52%
  • Histamine load
    +0.2no signal · 15%
  • Alcohol
    +0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 59
    • WearableHRV 32 ms, trending down
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 47
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 28/100
    • Daily logFibre intake low in recent food logs
  • Mucosal barrier integrity 50
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 59 and rising
  • Autonomic recovery 45
    • WearableResting HR 80 bpm
    • Wearable1,052 steps/day
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.1 · butyrate capacity 28/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
32 ms
Sleep
7.2 h
Steps
1,170
Resting HR
81 bpm
Daily log: GI score 59, nutritional resilience 41, adherence 41.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0160420%S0171
P-0138620%S1370
P-0135220%S2070
P-0169928%S04GI-04improved69
P-0150821%S1868
P-0150921%S1768
P-0181721%S1467
P-0187729%S01CR-01improved67
P-0162922%S1966
P-0171425%S14GI-04improved66
P-0185831%S14NP-02improved65
P-0131721%S1965